About Gelesis

Gelesis is a Boston-based company developing a breakthrough treatment for obesity and other related co-morbidities.

The Gelesis team of Scientific Advisors includes the world's top experts in obesity research and clinical development; former FDA and CDRH regulatory leaders; and innovators in advanced biomaterials.

Gelesis was founded by PureTech and has raised over $34M in financing and grants to date.